Trials / Completed
CompletedNCT04141085
Transcriptomic Evaluation of Endometrial Receptivity
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 63 (actual)
- Sponsor
- Reproductive Medicine Associates of New Jersey · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to comprehensively evaluate the transcriptomic signal of the endometrium before, during, and after the window of receptivity.
Detailed description
Phase 1 will aim to define a normal endometrial transcriptomic signature in healthy controls without infertility. Phase 2 will elucidate endometrial transcriptomic expression in patients with diagnoses of infertility unrelated to endometrial factor. Findings from this phase will be compared to the results of phase 1.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Endometrial biopsy | All groups will undergo a mock frozen embryo transfer cycle with an endometrial biopsy being performed as opposed to an embryo transfer |
Timeline
- Start date
- 2020-01-28
- Primary completion
- 2022-01-31
- Completion
- 2022-12-15
- First posted
- 2019-10-28
- Last updated
- 2023-05-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04141085. Inclusion in this directory is not an endorsement.